Candexch algorithm-enhanced chemometric determination of a novel anti-COVID-19 therapeutics in plasma and paxlovid formulation using advanced multivariate modeling: a sustainability-centered bioanalytical approach.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41975461

Ahmed Emad F Abbas; Michael K Halim; Mohamed R Elghobashy; Nisreen F Abo Talib; Omkulthom Al Kamaly

Apr 14, 2026